An Investigational New Drug Application (IND) is a submission to the US Food and Drug Administration (FDA) for permission to conduct a clinical trial of a medicinal product. This module describes regulatory requirements that sponsors or sponsor-investigators must meet for successful compilation, filing and maintenance of INDs. The IND and its role are defined, and the contexts in which it is required are specified.
During this 2 day course, you will develop a learning-based action plan to use in your workplace ensuring that you can put the learning into action.
During this 2 day course, you will develop a learning-based action plan to use in your workplace ensuring that you can put the learning into action.
During this 2 day course, you will develop a learning-based action plan to use in your workplace ensuring that you can put the learning into action.
Level 5 - Three QLS Endorsed Diploma | QLS Hard Copy Certificate Included | Plus 10 CPD Courses | Lifetime Access